Endeavor

Sarcoma Can’t Keep Senior Football Player Down

He missed graduation because of surgery, but Jefferson High School surprised him with a special ceremony

Improving Outcomes for Patients With Synovial Sarcoma

Moffitt treats first patient in the world with FDA-approved Tecelra

Honest Conversations Around Cancer

A three-time cancer survivor, Heidi Bragg tackles the toughest topics

Top Stories of 2024

Let's take a look back at Moffitt's top highlights of 2024

UFC Fighters Inspire Young Moffitt Patients Facing Cancer

They bond over similarities in their approach to life

Bolts Fight for a Cure at Hockey Fights Cancer Night

Tampa Bay Lightning game raises $30,000 for cancer research and patient services

Newly Approved Cell Therapy Afami-Cel Shows Long-Term Tumor Control in Synovial Sarcoma

Phase 2 clinical trial data suggests the engineered T cells can stay active in the body for more than three years

Revolutionizing Radiation Therapy for Soft Tissue Sarcomas

More than 60% of patients responded to habitat escalated adaptive therapy

FDA Approves New Gene Therapy for Rare Soft Tissue Cancer

First-of-its-kind treatment offers new hope for adults with advanced synovial sarcoma